CRISPR gene editing is in clinical trials to treat sickle cell disease, cancer, HIV/AIDS and some rare inherited diseases. Here’s what we can expect going forward

CRISPR gene editing is in clinical trials to treat sickle cell disease, cancer, HIV/AIDS and some rare inherited diseases. Here’s what we can expect going forward

Chemistry World | 
When Jennifer Doudna and Emmanuelle Charpentier revealed that the bacterial Crispr–Cas9 antiviral defence system could be reprogrammed to edit genomic ...

Your eye may be a window to your moral conscience

People asked to choose between two written moral statements tend to glance more often towards the option they favour, experimental ...

Quick and dirty gene exchanges not just for bacteria

A single gene from bacteria has been donated to fungi on at least 15 occasions. The discovery shows that an ...

Researchers sequence individual cancer cells, track their genetic divergence

The ability to sequence 100 human cancer genomes was unthinkable a decade ago, and it is still a remarkable feat ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists